Abstract
Dapsone is commonly used for the prophylaxis of Pneumocystis jiroveci pneumonia in patients with a diagnosis of HIV infection who have allergies to sulfa-based drugs. Dapsone has several adverse effects in its profile that make it a potentially dangerous second-line agent. We report an adverse effect encountered in an HIV-positive patient receiving dapsone and review the common adverse effects encountered with this alternative treatment option.
Original language | English |
---|---|
Pages (from-to) | 47-48+53-55 |
Journal | AIDS Reader |
Volume | 16 |
Issue number | 1 |
State | Published - 2006 |
Keywords
- Adverse drug reactions
- Dapsone
- HIV/AIDS
- Hypersensitivity reaction
- Pneumocystis
- Trimethoprimsulfamethoxazole